查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466810

细胞治疗市场：按细胞类型、治疗类型、应用和最终用户划分 - 2024-2030 年全球预测

Cell Therapy Market by Cell Type (Differentiated Cell, Stem Cell), Therapy Type (Allogenic Therapies, Autologous Therapies), Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年细胞治疗市场规模为86.6亿美元，预计2024年将达96亿美元，2030年将达179.1亿美元，复合年增长率为10.93%。

细胞治疗市场包括透过活细胞管理来治疗、缓解和预防疾病的产品和技术的研究、开发、製造和商业化。对再生医学的需求不断增长和细胞治疗的进步主要推动了细胞治疗市场的成长。研发投入不断增加，製药公司和研究机构之间的合作正在加速细胞治疗产品的研发。此外，支持性法律规范和突破性治疗方法的快速核准指定是市场的关键成长动力。然而，细胞治疗市场面临一些限制，例如治疗高成本、製造流程复杂以及可能延迟市场进入的严格监管要求。此外，与细胞疗法的储存、运输和保质期相关的挑战也是市场成长的主要挑战。此外，CRISPR/Cas9等基因编辑技术的突破为标靶细胞疗法开闢了新途径，有可能为以前无法治疗的疾病提供精准医疗解决方案。越来越多地采用 3D 生物列印和人工智慧来优化细胞治疗生产，这为未来的市场扩张带来了巨大的希望。

主要市场统计
基准年[2023] 86.6亿美元
预测年份 [2024] 96亿美元
预测年份 [2030] 179.1亿美元
复合年增长率（%） 10.93%

细胞类型：干细胞治疗应用的进展

分化细胞是已经成熟以在体内执行特定功能的特化细胞。分化细胞因其高度专业化和替换丢失或损坏的同源细胞的有效性而被用于细胞治疗。分化细胞的主要优点是它们比干细胞形成肿瘤的风险更低，这使得它们非常适合直接治疗应用。干细胞是未分化的细胞，可以进化成各种类型的细胞，在再生医学方面具有巨大的潜力。干细胞因其独特的自我更新和分化成多种细胞类型的能力而特别适合广泛的治疗应用。

治疗类型：越来越多地采用自体细胞疗法进行个人化医疗

同种异体细胞疗法涉及将来自基因不同的健康捐赠者的细胞移植到患者体内。同种异体细胞疗法并非针对个别患者，可以大量生产，并且通常被称为「现成的」。当患者需要立即治疗且没有时间收穫和扩增细胞时，优选同种异体细胞疗法。自体细胞疗法源自于患者自身的细胞，这些细胞被收穫、发育、必要时进行修饰，然后重新引入患者体内。自体细胞疗法是个人化医疗的理想型态，因为它是为每位患者量身定制的。对于需要患者自身细胞材料以消除免疫排斥可能性的治疗，通常选择自体细胞疗法。

应用：细胞疗法在皮肤科应用的进展

自体免疫疾病的细胞疗法旨在提供可调节或重置免疫系统的创新疗法。患有自体免疫疾病的患者需要能够提供长期缓解的治疗方法，并且不会产生与长期免疫抑制相关的副作用。再生细胞疗法为先前治疗选择有限的自体免疫疾病提供了潜在的治疗方法。细胞疗法在皮肤科的应用主要解决烧烫伤患者的皮肤修復、手术后重组、慢性伤口和美容皮肤再生。对于烧烫伤和慢性伤口的患者，细胞疗法可以加速癒合并减少疤痕组织的形成。皮肤病学和美容学应用利用再生能力来改善皮肤的外观和健康。肌肉骨骼系统的细胞疗法针对骨关节炎、骨折和软骨修復等疾病。细胞疗法的重点是利用干细胞的再生能力来修復和再生受损的组织。 CAR-T是治疗白血病、淋巴瘤和多发性骨髓瘤等癌症的突破性方法。

最终使用者：细胞疗法在医院和诊所疾病管理的多种应用

作为治疗解决方案的开发商和提供者，生物技术和製药公司是细胞治疗市场的主要最终用户。生技公司专注于发现、开发和商业化针对多种疾病的细胞疗法，包括癌症、自体免疫疾病和遗传性疾病。细胞科学的进步、对创新治疗方法的需求以及成功治疗方法带来的巨大经济回报的潜力推动了他们基于需求的偏好。医院和诊所是市场区隔的另一个重要部分，因为它们对于向患者进行细胞治疗至关重要。对特定细胞疗法的偏好通常取决于疗效、安全性、成本效益和报销政策。作为大型医疗网络或学术机构一部分的医院，由于其内部专业知识和基础设施，可能能够更好地采用新型细胞疗法。研究机构透过进行基础研究和转化研究并开发这一领域，在最终用户环境中发挥基础性作用。研究机构正在努力了解疾病机制并透过津贴和内部资助计划开发创新治疗方法。

区域洞察

在美洲，美国和加拿大凭藉着广泛的研究、大量的投资以及生物技术和製药巨头的积极参与，在细胞治疗方面处于领先地位。该地区的监管框架能够快速审查新型细胞疗法，并加速将新治疗方法推向市场的进程。欧洲国家正在透过公共和私营部门的各种伙伴关係和资助计划展示合作研究方法。欧盟的客户行为受到对国家资助的医疗保健系统的强烈偏见的影响，从而影响了细胞疗法的获取和负担能力。在中东和非洲，虽然以色列、阿联酋和沙乌地阿拉伯等国家在这一领域取得了长足的进步，但许多非洲国家仍在发展这一领域的能力，并且有着相似的外表。在亚太地区，中国、印度和日本政府启动了多项投资和改革，以加速该地区的细胞治疗研究和商业化。该地区癌症和遗传疾病的盛行率正在增加，对基于细胞的疾病管理疗法的需求也在显着增加。

FPNV定位矩阵

FPNV定位矩阵对于评估细胞治疗市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限。最前线 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市场占有率分析

市场占有率分析是一种综合工具，可以对细胞治疗市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该细分市场竞争特征的宝贵见解，包括在研究基准年观察到的累积、碎片化主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，以获得市场竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：包括新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：包括对未来技术、研发活动和突破性产品开发的智力见解。

本报告解决了以下关键问题：

1. 细胞治疗市场的市场规模与预测是多少？

2.在细胞治疗市场的预测期间内，有哪些产品、细分市场、应用和细分市场需要考虑投资？

3. 细胞治疗市场的技术趋势和法规结构是什么？

4.细胞治疗市场主要厂商的市场占有率是多少？

5. 进入细胞治疗市场的合适型态和策略性手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 政府增加对生物技术创新的投资和细胞疗法的核准率
      • 改善细胞治疗供应链
    • 抑制因素
      • 与干细胞移植相关的副作用
    • 机会
      • 嵌合体抗原受体 T 细胞 (CAR-T) 疗法以及 ESC（胚胎干细胞）和 iPSC（诱导性多功能干细胞）在癌症治疗中的应用取得进展
      • 增加干细胞在治疗神经系统疾病的应用
    • 任务
      • 与使用干细胞相关的伦理和药理学问题
  • 市场区隔分析
    • 细胞类型：干细胞治疗用途的进展
    • 治疗类型：在个人化医疗中越来越多地采用自体细胞疗法
    • 应用：细胞疗法在皮肤科应用的进展
    • 最终使用者：细胞疗法在医院和诊所疾病管理的多种应用
  • 市场趋势分析
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析
  • 客户客製化

第六章细胞治疗市场：依细胞类型

  • 介绍
  • 分化细胞
  • 干细胞

第七章细胞治疗市场：依治疗类型

  • 介绍
  • 同种异体疗法
  • 家庭治疗

第八章细胞治疗市场：依应用分类

  • 介绍
  • 自体免疫疾病
  • 皮肤科
  • 肌肉骨骼治疗
  • 肿瘤学

第九章细胞治疗市场：依最终使用者分类

  • 介绍
  • 生物技术和製药公司
  • 医院和诊所
  • 研究机构

第十章美洲细胞治疗市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太细胞治疗市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲细胞治疗市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-433AB1DC28D4

[192 Pages Report] The Cell Therapy Market size was estimated at USD 8.66 billion in 2023 and expected to reach USD 9.60 billion in 2024, at a CAGR 10.93% to reach USD 17.91 billion by 2030.

The cell therapy market encompasses the research, development, manufacturing, and commercialization of products and techniques aimed at treating, mitigating, or preventing diseases by administering living cells. The escalating demand for regenerative medicine and advancements in cellular therapeutics primarily drives the growth of the cell therapy market. The rising investment in research and development and collaborative efforts between pharmaceutical companies and research institutions have accelerated the pipeline for cell therapy products. Furthermore, supportive regulatory frameworks and the designation of fast-track approvals for groundbreaking therapies have been crucial growth stimulants for the market. However, the cell therapy market faces several limitations, such as the high cost of therapies, intricate manufacturing processes, and stringent regulatory requirements, which may slow down market entry. Issues related to the preservation, transport, and shelf-life of cell therapies also present substantial challenges in the market growth. Moreover, breakthroughs in gene editing technologies such as CRISPR/Cas9 have opened new avenues for targeted cell therapies, which could offer precision medicine solutions for previously untreatable conditions. The increasing adoption of 3D bioprinting and artificial intelligence for optimizing cell therapy production holds significant promise for future market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 8.66 billion
Estimated Year [2024] USD 9.60 billion
Forecast Year [2030] USD 17.91 billion
CAGR (%) 10.93%

Cell Type: Advancements in stem cells for therapeutic applications

Differentiated cells are specialized cells that have matured to perform a specific function in the body. Differentiated cells are used in cell therapy due to their high specialization and efficacy in replacing lost or damaged cells of the same type. The significant advantage of differentiated cells lies in their lower risk of tumor formation than stem cells, making them highly preferable for direct therapeutic applications. Stem cells are undifferentiated cells that can evolve into various types of cells and hold enormous potential for regenerative medicine. Stem cells are particularly used for their unique capabilities to self-renew and differentiate into multiple cell types, making them suitable for a broad range of therapeutic applications.

Therapy Type: Increasing adoption of autologous cell therapies for personalized medicines

Allogeneic cell therapies involve transplanting cells from a healthy, genetically different donor into a patient. Allogeneic cell therapies are not specific to the individual patient and can be manufactured in larger batches, often called "off-the-shelf" products. Allogeneic therapies are preferred when patients require immediate treatment and do not have time to harvest and expand their cells. Autologous cell therapies are derived from the patient's own cells, which are collected, developed, modified if needed, and then reintroduced into the patient's body. Autologous cell therapies are uniquely tailored to each patient, making them an ideal form of personalized medicine. Autologous therapies are often the choice for treatments requiring the patient's own cellular material to eliminate chances of immunological rejection.

Application: Advancements in dermatological applications of cell therapies

Cell therapies for autoimmune diseases aim to provide innovative treatments that can modulate or reset the immune system. Autoimmune patients require treatments that can provide long-term relief without the adverse effects associated with long-term immunosuppression. Regenerative cell therapies offer potential cures for autoimmune disease conditions that previously had limited treatment options. The application of cell therapies in dermatology primarily addresses skin regeneration for burn victims, reconstruction following surgery, chronic wounds, and cosmetic skin rejuvenation. For patients suffering from burns or chronic wounds, cell therapies accelerate healing and reduce scar tissue formation. Dermatological & cosmetic applications leverage regenerative capabilities to improve skin appearance and health. Cell therapies in the musculoskeletal domain target conditions such as osteoarthritis, bone fractures, and cartilage repair. Cell therapies focus on harnessing the regenerative potential of stem cells for repair and regenerate damaged tissues. Cell therapy plays a critical role in oncology, with CAR-T cell therapy being a revolutionary approach in cancer treatment, including leukemia, lymphoma, and multiple myeloma.

End-User: Diverse applications of cell therapies in hospitals and clinics for disease management

Biotechnology and pharmaceutical companies are primary end-users in the cell therapy market as developers and providers of therapeutic solutions. Biotechnology companies focus on the discovery, development, and commercialization of cell therapies for a variety of diseases, including cancer, autoimmune disorders, and genetic diseases. Their need-based preference is driven by advancements in cellular science, the demand for innovative treatments, and the potential for significant financial returns from successful therapies. Hospitals and clinics represent another crucial segment in the cell therapy market, as they are essential for administering cell therapies to patients. The preference for specific cell therapies often depends on efficacy, safety profiles, cost-effectiveness, and reimbursement policies. Hospitals affiliated with large healthcare networks or academic institutions may have a greater capacity for adopting novel cell therapies due to in-house expertise and infrastructure. Research institutes serve a fundamental role in the cell therapy end-user landscape by conducting basic and translational research to advance the field. Research institutes seek to understand disease mechanisms and develop innovative therapies through grant-funded or internally-financed projects.

Regional Insights

In the Americas region, the United States and Canada lead in cell therapy advancements, driven by significant research, heavy investment, and active participation from biotechnological and pharmaceutical giants. The regulatory framework in the region allows for an expedited review of novel cell therapies, hastening up the process of bringing new treatments to market. The European countries exhibit a cooperative approach towards cell therapy research, with various cross-country partnerships and funding programs supported by public and private sectors. Customer behavior in the EU is influenced by a strong predisposition towards state-funded healthcare systems, which affects access to and affordability of cell therapies. The Middle East and Africa (MEA) present a diverse picture, with countries such as Israel, UAE, and Saudi Arabia taking strides in cell therapy, while many African nations are still developing capabilities in this area. In the APAC region, the governments in China, India, and Japan have initiated several investments and reforms to fast-track local cell therapy research and commercialization. The rising prevalence of cancers and genetic diseases in the region is significantly increasing the need for cell-based therapies for disease management.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell Therapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Therapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Therapy Market, highlighting leading vendors and their innovative profiles. These include Anterogen Co., Ltd., Astellas Pharma Inc., Athersys, Inc., BioNTech SE, Bone Therapeutics SA, Bristol-Myers Squibb Company, Castle Creek Biosciences, Inc., FUJIFILM Holdings Corporation, Gilead Sciences, Inc., JCR Pharmaceuticals Co., Ltd., Kolon TissueGene, Inc., Lonza Group Ltd., Medipost Co., Ltd., Mesoblast Ltd., Novartis AG, NuVasive, Inc., Pfizer Inc., Sartorius AG, Smith & Nephew PLC, Stemedica Cell Technologies, Inc., Stempeutics Research Pvt. Ltd., Takeda Pharmaceutical Company Limited, TegoScience, Thermo Fisher Scientific, Inc., and Vericel Corporation.

Market Segmentation & Coverage

This research report categorizes the Cell Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Cell Type
    • Differentiated Cell
    • Stem Cell
  • Therapy Type
    • Allogenic Therapies
    • Autologous Therapies
  • Application
    • Autoimmune Diseases
    • Dermatology
    • Musculoskeletal Therapies
    • Oncology
  • End-User
    • Biotechnology and Pharmaceutical Companies
    • Hospitals and Clinics
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cell Therapy Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Therapy Market?

3. What are the technology trends and regulatory frameworks in the Cell Therapy Market?

4. What is the market share of the leading vendors in the Cell Therapy Market?

5. Which modes and strategic moves are suitable for entering the Cell Therapy Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Government Investment in Biotech Innovation and Approval Rates in Cell Therapy
      • 5.1.1.2. Improvements in Cell Therapy Supply Chain
    • 5.1.2. Restraints
      • 5.1.2.1. Side Effects Related to the Stem Cell Transplant
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in Chimeric Antigen Receptor T-cell (CAR-T) Therapies for Cancer Treatments and the Use of ESCs (Embryonic stem cells) and iPSCs (Induced Pluripotent Stem Cells)
      • 5.1.3.2. Increasing Use of Stem Cells for the Treatment of Neurological disorders
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical Issues Associated with the Use of Stem Cells and Pharmacological Issues
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Cell Type: Advancements in stem cells for therapeutic applications
    • 5.2.2. Therapy Type: Increasing adoption of autologous cell therapies for personalized medicines
    • 5.2.3. Application: Advancements in dermatological applications of cell therapies
    • 5.2.4. End-User: Diverse applications of cell therapies in hospitals and clinics for disease management
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Cell Therapy Market, by Cell Type

  • 6.1. Introduction
  • 6.2. Differentiated Cell
  • 6.3. Stem Cell

7. Cell Therapy Market, by Therapy Type

  • 7.1. Introduction
  • 7.2. Allogenic Therapies
  • 7.3. Autologous Therapies

8. Cell Therapy Market, by Application

  • 8.1. Introduction
  • 8.2. Autoimmune Diseases
  • 8.3. Dermatology
  • 8.4. Musculoskeletal Therapies
  • 8.5. Oncology

9. Cell Therapy Market, by End-User

  • 9.1. Introduction
  • 9.2. Biotechnology and Pharmaceutical Companies
  • 9.3. Hospitals and Clinics
  • 9.4. Research Institutes

10. Americas Cell Therapy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cell Therapy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cell Therapy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Pluri Launches New Cell Therapy CDMO Division
    • 13.3.2. Max Healthcare Launches CAR-T Cell Therapy to Improve Cancer Care in Delhi-NCR
    • 13.3.3. Bayer Opens First Cell Therapy Manufacturing Facility to Advance Regenerative Medicines on a Global Scale

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CELL THERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. CELL THERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CELL THERAPY MARKET DYNAMICS
  • FIGURE 7. GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. CELL THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. CELL THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELL THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELL THERAPY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CELL THERAPY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL THERAPY MARKET SIZE, BY DIFFERENTIATED CELL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CELL THERAPY MARKET SIZE, BY DIFFERENTIATED CELL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL THERAPY MARKET SIZE, BY STEM CELL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CELL THERAPY MARKET SIZE, BY STEM CELL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL THERAPY MARKET SIZE, BY ALLOGENIC THERAPIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CELL THERAPY MARKET SIZE, BY ALLOGENIC THERAPIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CELL THERAPY MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CELL THERAPY MARKET SIZE, BY DERMATOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CELL THERAPY MARKET SIZE, BY MUSCULOSKELETAL THERAPIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CELL THERAPY MARKET SIZE, BY MUSCULOSKELETAL THERAPIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CELL THERAPY MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CELL THERAPY MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CELL THERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CELL THERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CELL THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CELL THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. BRAZIL CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 60. BRAZIL CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. CANADA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. CANADA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. CANADA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 70. CANADA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 71. MEXICO CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. MEXICO CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. MEXICO CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. MEXICO CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. MEXICO CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 78. MEXICO CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 83. UNITED STATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. UNITED STATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. UNITED STATES CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. UNITED STATES CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 88. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. AUSTRALIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. AUSTRALIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 104. AUSTRALIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. AUSTRALIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. CHINA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. CHINA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. CHINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. CHINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. CHINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. CHINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. CHINA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 114. CHINA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 115. INDIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. INDIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. INDIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 118. INDIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 119. INDIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. INDIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. INDIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 122. INDIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 123. INDONESIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. INDONESIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. INDONESIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. INDONESIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. INDONESIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. INDONESIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. INDONESIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. INDONESIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. JAPAN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. JAPAN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. JAPAN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. JAPAN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. JAPAN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. JAPAN CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. JAPAN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 138. JAPAN CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 139. MALAYSIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. MALAYSIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. MALAYSIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. MALAYSIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. MALAYSIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. MALAYSIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. MALAYSIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 146. MALAYSIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. PHILIPPINES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. PHILIPPINES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. PHILIPPINES CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. PHILIPPINES CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. SINGAPORE CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. SINGAPORE CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. SINGAPORE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. SINGAPORE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. SINGAPORE CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. SINGAPORE CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. SINGAPORE CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 162. SINGAPORE CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. SOUTH KOREA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH KOREA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. SOUTH KOREA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH KOREA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. TAIWAN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. TAIWAN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. TAIWAN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. TAIWAN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. TAIWAN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. TAIWAN CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. TAIWAN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 178. TAIWAN CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 179. THAILAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. THAILAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. THAILAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. THAILAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. THAILAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. THAILAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. THAILAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. THAILAND CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. VIETNAM CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. VIETNAM CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. VIETNAM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. VIETNAM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. VIETNAM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. VIETNAM CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. VIETNAM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 194. VIETNAM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 205. DENMARK CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. DENMARK CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. DENMARK CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. DENMARK CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. DENMARK CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. DENMARK CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. DENMARK CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 212. DENMARK CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 213. EGYPT CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. EGYPT CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. EGYPT CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. EGYPT CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. EGYPT CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. EGYPT CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. EGYPT CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. EGYPT CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. FINLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. FINLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. FINLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. FINLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. FINLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. FINLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. FINLAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. FINLAND CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. FRANCE CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. FRANCE CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. FRANCE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. FRANCE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. FRANCE CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. FRANCE CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. FRANCE CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 236. FRANCE CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 237. GERMANY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. GERMANY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. GERMANY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 240. GERMANY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 241. GERMANY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. GERMANY CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. GERMANY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 244. GERMANY CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 245. ISRAEL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. ISRAEL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. ISRAEL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. ISRAEL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. ISRAEL CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 250. ISRAEL CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 251. ISRAEL CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 252. ISRAEL CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 253. ITALY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. ITALY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. ITALY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. ITALY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. ITALY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. ITALY CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. ITALY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 260. ITALY CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. NETHERLANDS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. NETHERLANDS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. NETHERLANDS CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. NETHERLANDS CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. NIGERIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. NIGERIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. NIGERIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. NIGERIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. NIGERIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 274. NIGERIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 275. NIGERIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 276. NIGERIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 277. NORWAY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. NORWAY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. NORWAY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. NORWAY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. NORWAY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. NORWAY CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. NORWAY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 284. NORWAY CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 285. POLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. POLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. POLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 288. POLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 289. POLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 290. POLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 291. POLAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 292. POLAND CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 293. QATAR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. QATAR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. QATAR CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 296. QATAR CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 297. QATAR CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 298. QATAR CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 299. QATAR CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 300. QATAR CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 301. RUSSIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 302. RUSSIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 303. RUSSIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 304. RUSSIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 305. RUSSIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 306. RUSSIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 307. RUSSIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 308. RUSSIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 310. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 312. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 314. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 316. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 318. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 322. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 324. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 325. SPAIN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 326. SPAIN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 327. SPAIN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 328. SPAIN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 329. SPAIN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 330. SPAIN CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 331. SPAIN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 332. SPAIN CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 333. SWEDEN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 334. SWEDEN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 335. SWEDEN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 336. SWEDEN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 337. SWEDEN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 338. SWEDEN CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 339. SWEDEN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 340. SWEDEN CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 342. SWITZERLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 344. SWITZERLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 346. SWITZERLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 347. SWITZERLAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 348. SWITZERLAND CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 349. TURKEY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 350. TURKEY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 351. TURKEY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 352. TURKEY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 353. TURKEY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 354. TURKEY CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 355. TURKEY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 356. TURKEY CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 357. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 358. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 360. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 361. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 362. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 363. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 364. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 365. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
  • TABLE 366. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
  • TABLE 367. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 368. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 369. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 370. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 371. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 372. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 373. CELL THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 374. CELL THERAPY MARKET, FPNV POSITIONING MATRIX, 2023